Byotrol PLC Key US Hire & Grant of Options (2849Z)
December 14 2017 - 1:01AM
UK Regulatory
TIDMBYOT
RNS Number : 2849Z
Byotrol PLC
14 December 2017
14(th) December, 2017
Byotrol plc
('Byotrol', the 'Group' or the 'Company')
KEY US HIRE
AND GRANT OF SHARE OPTIONS
Byotrol plc the AIM listed anti-microbial technology company, is
pleased to announce the appointment of sales and marketing
leadership for its wholly-owned US subsidiary Byotrol, Inc.
Alex Espalin has been advising Byotrol for twelve months on its
commercialisation efforts in the US and has been key to getting the
Company positioned to launch its US EPA-approved long-lasting
surface care formulation. He has now joined the Company formally as
VP Sales and Marketing, Byotrol Inc.
Alex brings to Byotrol broad marketing, branding, management and
entrepreneurial expertise, gained over a twenty-year corporate and
entrepreneurial career including roles at Coca-Cola, Disney and
Kimberly-Clark, where he had oversight for multiple new product
launches.
Alex earned his Bachelor of Science degree from Cornell
University, an MBA from the University of Michigan and a Masters
Degree in economic development from Harvard University
Alex Espalin has today been awarded 5 million share options in
Byotrol plc at 4p, representing 1.24% of Byotrol plc fully diluted
share capital. These options mature in dates varying up to 7 years
from grant and will vest in three tranches when Byotrol Inc
achieves a successful consumer product launch and/or certain US
sales and profitability targets.
David Traynor, Chief Executive of Byotrol, said:
"We are delighted that Alex has joined the Company. He is
entrepreneurial by nature, has excellent experience across B2B and
B2C and we believe will be pivotal in building a business of
quality for Byotrol in the US."
Enquiries:
Byotrol plc
David Traynor - Chief Executive 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Stephen Norcross/Richard Chambers - Corporate Broking
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial
technology company, operating globally in the Food, Industrial,
Healthcare and Consumer sectors, providing low toxicity products
with a broad-based and long-lasting efficacy across all microbial
classes; bacteria, viruses, fungi, moulds, mycobacteria and
algae.
Powerful, long-lasting and gentle, Byotrol's products can be
used stand-alone or as ingredients within existing products, where
Byotrol can significantly improve their performance, especially in
personal hygiene, domestic and industrial disinfection, odour
control, food production and food management.
Founded in 2005, the Company develops technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk
Accordingly, the Company makes the following announcement and
notification in accordance with the EU Market Abuse Regulation (No
596/2014):
1. Details of the person discharging managerial responsibilities
/ person closely associated
---------- -----------------------------------------------------------------------
a) Name Alex Espalin
---------- ------------------------------- --------------------------------------
2. Reason for the Notification
---------- -----------------------------------------------------------------------
a) Position/status PDMR
---------- ------------------------------- --------------------------------------
b) Initial notification/Amendment Initial
---------- ------------------------------- --------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------- -----------------------------------------------------------------------
a) Name Byotrol Plc
---------- ------------------------------- --------------------------------------
b) LEI 213800AJMTSTIPA59A34
---------- ------------------------------- --------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------- -----------------------------------------------------------------------
a) Description of the options over ordinary shares of 0.25p
Financial instrument, each
type of instrument
----------
Identification code GB00B0999995
---------- ------------------------------- --------------------------------------
b) Nature of the transaction Award of Options to subscribe for
Ordinary Shares
---------- ------------------------------- --------------------------------------
c) Price(s) and volume(s) Volume - 5,000,000
Exercise Price - 4 pence
---------- ------------------------------- --------------------------------------
d) Aggregated information: See 4c) above
---------- ------------------------------- --------------------------------------
e) Date of the transaction 14 December 2017
---------- ------------------------------- --------------------------------------
f) Place of the transaction Outside of a trading venue
---------- ------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUOSNRBVAUAAA
(END) Dow Jones Newswires
December 14, 2017 02:01 ET (07:01 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024